Remodeling of sorafenib as an orally bioavailable ferroptosis inducer for Lung Cancer by chemical modification of adenine-binding motif

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Biomedicine & Pharmacotherapy

Topics

Chemistry

Biochemistry

Medicine

Internal Medicine

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.1016/j.biopha.2024.116758

License

CC-BY-NC